Guardant Health Inc (NASDAQ:GH) price on Thursday, May 01, rose 3.47% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $48.87.
A look at the stock’s price movement, the close in the last trading session was $47.23, moving within a range at $47.1199 and $52.92. Turning to its 52-week performance, $50.89 and $17.85 were the 52-week high and 52-week low respectively. Overall, GH moved 15.07% over the past month.
Guardant Health Inc’s market cap currently stands at around $6.03 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-29.
Analysts have a consensus estimate of 211.27M for the company’s revenue for the quarter, with a low and high estimate of 202.02M and 219.1M respectively. The average forecast suggests up to a 19.20% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 879.58M, representing a 19.02% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GH is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
13 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 13 recommend GH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GH’s current price about 9.27% and 11.85% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.48, while 7-day volatility ratio is 6.25% and 7.17% in the 30-day chart. Further, Guardant Health Inc (GH) has a beta value of 1.49, and an average true range (ATR) of 3.12. Analysts have given the company’s stock an average 52-week price target of $52, forecast between a low of $52 and high of $52. Looking at the price targets, the low is -6.4% off current price level while to achieve the yearly target high, price needs to move -6.4%. Nonetheless, investors will most likely welcome a -6.4% jump to $52 which is the analysts’ median price.
If we refocus on Guardant Health Inc (NASDAQ:GH), historical trading data shows that trading volumes averaged 2.4 over the past 10 days and 2.19 million over the past 3 months. The company’s latest data on shares outstanding shows there are 123.99 million shares.
The 5.17% of Guardant Health Inc’s shares are in the hands of company insiders while institutional holders own 97.71% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.62 million on 2025-04-15, giving us a short ratio of 4.11. The data shows that as of 2025-04-15 short interest in Guardant Health Inc (GH) stood at 643.0 of shares outstanding, with shares short falling to 8.35 million registered in 2025-03-14. Current price change has pushed the stock 59.97% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GH stock continues to rise going into the next quarter.
